MedPath

Patient awareness survey on adverse events of glaucoma medications

Not Applicable
Conditions
Glaucoma
Registration Number
JPRN-UMIN000040798
Lead Sponsor
Santen Pharmaceutical Co., Ltd.
Brief Summary

It was found that PAP adverse events associated with glaucoma eye drop treatment may be as emotionally taxing for patients as adverse events directly felt physically. This was a web-based survey conducted without a physician, and it can be considered that the burden of patients who cannot speak their true feelings in front of a physician became apparent.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Those have history of open surgery (including laser treatment) for glaucoma Those attending psychiatric or psychosomatic department Medical professinals (doctors, pharmacists, nurses, etc.) Those engaged in the manufacturing of pharmaceuticals and medical producsts Person engaged in drug marketing Those engaged in information provision services, research services and advertising

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath